New research has concluded that screening for a genetic condition in younger people who are diagnosed with bowel cancer would be cost-effective for the NHS. Researchers at the University of Exeter Medical School were funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme to assess the effectiveness and cost-effectiveness of screening for Lynch Syndrome. Their findings, published in iHealth Technology Assessment/i, ...
Read More
You have just read an article categorized health
titled Genetic Test for Cancer Patients Could be Cost-Effective, Claims Research.
Written by:
editor -
Thursday, October 2, 2014
There are currently no comments for "Genetic Test for Cancer Patients Could be Cost-Effective, Claims Research"
Post a Comment